Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index; 16 of the 42 sources its claims cite were checked for support.

Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose-response meta-analysis of randomized controlled trials

Open access
Yang, Chao, Xia, Hui, Wan, Min, Lu, Yifei, Xu, Dengfeng, Yang, Xian, Yang, Ligang, Sun, Guiju · 2021 · Nutrition & Metabolism

Abstract

This systematic review and dose-response meta-analysis of randomized controlled trials evaluated effects of different flaxseed products on lipid profiles and inflammatory parameters in patients with dyslipidemia related diseases.

Overview

CoChat Summary

## TL;DR

This systematic review and dose-response meta-analysis of 31 RCTs (1,698 participants) found that flaxseed products had beneficial effects on several lipid, inflammatory, and some anthropometric outcomes in patients with dyslipidemia-related diseases, but effects differed by product type. Whole flaxseed and lignans mainly improved lipid measures, while flaxseed oil mainly reduced inflammatory markers.

## Key findings

  • 31 RCTs involving 1,698 participants were included; 875 were assigned to flaxseed interventions and 823 to controls.
  • Overall, flaxseed-containing products significantly reduced total cholesterol (TC) by WMD −8.73 mg/dL, LDL-C by WMD −6.92 mg/dL, triglycerides (TG) by WMD −12.31 mg/dL, apo B by WMD −4.70 mg/dL, and IL-6 by WMD −0.23 pg/mL.
  • Whole flaxseed significantly reduced TC (−11.85 mg/dL), LDL-C (−10.51 mg/dL in the abstract; −10.52 mg/mL in the dose subgroup text), TG (−19.77 mg/dL), apo B (−5.73 mg/dL in the abstract; −5.50 mg/dL in the detailed results), TC/HDL-C (−0.10), and weight (−0.40 kg).
  • Lignans significantly reduced TC (−17.86 mg/dL), LDL-C (−15.47 mg/dL), and TC/HDL-C (−0.45), while flaxseed oil significantly reduced IL-6 (−0.35 pg/mL) and hs-CRP (−1.54 mg/L).
  • No significant effects were seen for HDL-C, apo B/apo A ratio, CRP, TNF-α, BMI, WC overall, or WHR overall.

## Methods

  • Systematic review and dose-response meta-analysis of randomized controlled trials in adults with dyslipidemia-related diseases, following PRISMA.
  • Searches were run in PubMed, Embase, Cochrane Library, Scopus, and Web of Science from inception to January 2020; only human studies in English were included.
  • Pooled weighted mean differences were calculated with fixed- or random-effects models; heterogeneity was assessed with Q and I², with meta-regression, subgroup analyses, sensitivity analyses, and Egger’s test used to explore moderators, robustness, and publication bias.

## Limitations

  • The paper states that many SDs of net change were estimated using correlation-based methods rather than exact values.
  • It states that between-study heterogeneity could not be fully removed because of differing patient backgrounds, control groups, and uneven study quality.
  • It states that some studies may have been missed because grey literature was not searched and non-English studies were excluded.
  • The text also makes evident that several outcomes had high heterogeneity and some publication bias signals (for example, TC and LDL-C), which limits confidence in pooled estimates.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12986-021-00619-3

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Effect of different flaxseed products on net changes (95% CI) of a TC, b LDL-C, c HDL-C and d TG in patients with dyslipidemia related diseases; (1) and (2) represent the low dose and high dose in two studies (Zhang et al. and Fukumitsu et al. respectively); a and b represent brown and golden flaxseed interventions respectively in the study by Machado et al.; (I) and (II) represent short and long intervention time respectively in the study by Bloedon et al.
Fig. 1 Effect of different flaxseed products on net changes (95% CI) of a TC, b LDL-C, c HDL-C and d TG in patients with dyslipidemia related diseases; (1) and (2) represent the low dose and high dose in two studies (Zhang et al. and Fukumitsu et al. respectively); a and b represent brown and golden flaxseed interventions respectively in the study by Machado et al.; (I) and (II) represent short and long intervention time respectively in the study by Bloedon et al.CC BY · PubMed Central
Fig. 2 Effect of different flaxseed products on net changes (95% CI) of a TC/HDL-C, b apo A, c apo B and d apo A/apo B in patients with dyslipidemia related diseases; (1) and (2) represent the low dose and high dose in two studies (Zhang et al. and Fukumitsu et al. respectively); a and b represent brown and golden flaxseed interventions respectively in the study by Machado et al.; (I) and (II) represent short and long intervention time respectively in the study by Bloedon et al.
Fig. 2 Effect of different flaxseed products on net changes (95% CI) of a TC/HDL-C, b apo A, c apo B and d apo A/apo B in patients with dyslipidemia related diseases; (1) and (2) represent the low dose and high dose in two studies (Zhang et al. and Fukumitsu et al. respectively); a and b represent brown and golden flaxseed interventions respectively in the study by Machado et al.; (I) and (II) represent short and long intervention time respectively in the study by Bloedon et al.CC BY · PubMed Central
Fig. 3 Effect of different flaxseed products on net changes (95% CI) of a IL-6, b CRP, c hs-CRP and d TNF-α in patients with dyslipidemia related diseases; a and b represent brown and golden flaxseed interventions respectively in the study by Machado et al.; (L) and (H) represent the low dose and high dose in respectively in the study by Hutchins et al.
Fig. 3 Effect of different flaxseed products on net changes (95% CI) of a IL-6, b CRP, c hs-CRP and d TNF-α in patients with dyslipidemia related diseases; a and b represent brown and golden flaxseed interventions respectively in the study by Machado et al.; (L) and (H) represent the low dose and high dose in respectively in the study by Hutchins et al.CC BY · PubMed Central
Fig. 4 Effect of different flaxseed products on net changes (95% CI) of a weight, b BMI, c WC and d WHR in patients with dyslipidemia related diseases; a and b represent brown and golden flaxseed interventions respectively in the study by Machado et al.
Fig. 4 Effect of different flaxseed products on net changes (95% CI) of a weight, b BMI, c WC and d WHR in patients with dyslipidemia related diseases; a and b represent brown and golden flaxseed interventions respectively in the study by Machado et al.CC BY · PubMed Central
Fig. 5 Random-effects meta-regression plot of the association between dose of whole flaxseed (g/day) and weighted mean difference of C-reactive protein (CRP)
Fig. 5 Random-effects meta-regression plot of the association between dose of whole flaxseed (g/day) and weighted mean difference of C-reactive protein (CRP)CC BY · PubMed Central
Fig. 6 Curvilinear regression plot of the association between dose of whole flaxseed (g/day) and weighted mean difference of IL-6
Fig. 6 Curvilinear regression plot of the association between dose of whole flaxseed (g/day) and weighted mean difference of IL-6CC BY · PubMed Central

Verification

Claims the paper makes

9 Valid · 2 Not valid · 13 Not checked · 111 Own results and interpretations

87 more claims

Create a free account to see all 135 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 25
  • Probably not a substantial claim. 19
  • The quote only partly states this claim. 4

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 95 references

Cited by

See all 40

Metadata

Authors
Yang, C., Xia, H., Wan, M., Lu, Y., Xu, D., Yang, X., Yang, L., & Sun, G.
Affiliations
Southeast University (CN)
Corresponding author
Sun, Guiju
Venue
Nutrition & Metabolism
Published
2021-10-11
Volume
18
Issue
1
Pages
91-91
ISSN
1743-7075 (ISSN-L)
OpenAlex
W3207254176
Cited by
40
References
95
Citations by year
2026: 7 · 2025: 14 · 2024: 8 · 2023: 3 · 2022: 8
FWCI
0.63
Type
journal article
Language
en
Open access
Licence
Locations
  • Nutrition & Metabolism (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81872618, 82073551)
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX19_0121)
  • Scientific Research Foundation of Graduate School of Southeast University (YBPY1944)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Nursing › Nutrition and Dietetics › Food composition and properties
Keywords
flaxseed, linseed oil, lignans, dyslipidemia, lipid profile, LDL cholesterol, triglycerides, apolipoprotein B, inflammatory cytokines, interleukin-6, C-reactive protein, anthropometric indices, weight, dose-response relationship, functional foods, dietary supplementation, linolenic acid, dietary fiber, TC/HDL-C ratio, HDL cholesterol

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose-response meta-analysis of randomized controlled trials. https://app.cochat.ai/papers/10.1186/s12986-021-00619-3
The paper
Yang, C., Xia, H., Wan, M., Lu, Y., Xu, D., Yang, X., Yang, L., & Sun, G. (2021). Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose-response meta-analysis of randomized controlled trials. Nutrition & Metabolism. https://doi.org/10.1186/s12986-021-00619-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.